Investors

OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians’ offices, and commercial and industrial entities.
More>>
Featured Reports
2015 Annual Report on Form 10-K - PDF 2015 Annual Report on Form 10-K
OSUR (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$7.76
Change (%) Stock is Up 0.02 (0.00%)
Volume991,608
Data as of 08/25/16 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore >>
DateTitle 
08/23/16OraSure Awarded Up to $16.6 Million to Advance Rapid Zika Tests
BETHLEHEM, Pa., Aug. 23, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, announced today that it has been awarded a contract for up to $16.6 million in total funding from the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response’s Biomedical Advanced Research and Development Authority (BARDA) to advance the Company’s rapid Zika tests. Th... 
Printer Friendly Version
08/03/16OraSure Announces 2016 Second Quarter Financial Results
BETHLEHEM, Pa., Aug. 03, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced its consolidated financial results for the three and six months ended June 30, 2016. Financial Highlights Consolidated net revenues for the second quarter of 2016 were $31.4 million, a 3% increase from the second quarter of 2015. Consolidated net revenues for the six months ended June 30, 2016 were $60.4 ... 
Printer Friendly Version
08/01/16OraSure Technologies to Present at the Canaccord Genuity 36th Annual Growth Conference
BETHLEHEM, Pa., Aug. 01, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the Canaccord Genuity 36th Annual Growth Conference in Boston, Massachusetts.  The conference will be simultaneously webcast over the Internet. Mr. Michels is scheduled to speak August 10, 2016, at approximately 9:30 AM Easte... 
Printer Friendly Version
07/13/16OraSure Technologies Earnings Conference Call Invitation
2016 Second Quarter Earnings Conference Call Wednesday, August 3, 2016, 5:00 p.m. ET BETHLEHEM, Pa., July 13, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) has scheduled its regular earnings conference call covering 2016 second quarter financial results, 2016 third quarter financial guidance and certain business developments for 5:00 pm ET (2:00 pm PT) on Wednesday, August 3, 2016.      August 3, 2016 Schedule       ... 
Printer Friendly Version
Upcoming EventsMore >>
There are currently no events scheduled.
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources



Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | IR Contacts IR Contacts | Financial Tear Sheet Financial Tear Sheet